ArticleBMC cancer2018

Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study.

Hwi Young Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.